Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Pharma
Teva, Samsung Bioepis deepen biosimilar bonds with new deal
Already sharing the load on two biosimilar assets, Teva Pharmaceutical and Samsung Bioepis have elected to take their partnership to the next level.
Fraiser Kansteiner
Oct 2, 2026 10:00am
BMS, Ono sue Amgen over proposed Opdivo biosimilar
Sep 16, 2026 11:08am
Sandoz sets ambitious goal to grow biosimilar bona fides by 2040
Sep 8, 2026 2:45pm
Sandoz, Henlius agree to $322M deal for 3 biosimilars
Aug 17, 2026 10:46am
Novo, Alvotech written up after FDA site inspections
Jul 17, 2026 10:56am
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
